Dec 1, 2025 Log in

調查

KANBO Biotech 2025 Q4 Financials

Citation-Grade Primary-source linked Schema.org verified NQ 58 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Dec 1, 2025 9:00 AM ・ Updated Jun 13, 2026 11:52 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

KANBO Biotech (6919), a biotechnology and medical care company, reported a basic EPS of -0.23 NTD for Q4 2025, with operating revenue of 0.038 billion NTD and a net loss of 0.352 billion NTD after tax.

KANBO Biotech (6919), a biotechnology and medical care company, reported a basic EPS of -0.23 NTD for Q4 2025, with operating revenue of 0.038 billion NTD and a net loss of 0.352 billion NTD after tax.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/financial/twse-fin-6919-2025Q4 Distributor: PR Times
Published: Dec 1, 2025

Company Code: 6919. Company Name: KANBO Biotech Co., Ltd. Industry: Biotechnology and Medical Care. Year/Quarter: 2025 Q4. Basic Earnings Per Share: -0.23 NTD. Operating Revenue: 0.038 billion NTD. Net Income After Tax: -0.352 billion NTD.

FACT BOX

Source: PR Times
Category: 調查

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Dec 1, 2025 9:00 AM — Distributor PR Times
Collected　Apr 8, 2026 8:00 AM
AI structured & analyzed　Apr 11, 2026 9:07 PM
Desk-reviewed & published　Dec 1, 2025 9:00 AM

FAQ

康霈生技在2025年第四季的獲利狀況如何？

該公司在2025年第四季稅後淨利為-3.52億元，基本每股盈餘為-0.23元。

What was Kang Pei Biotech's profitability in Q4 2025?

In the fourth quarter of 2025, the company reported a net profit after tax of -3.52 billion yuan and basic earnings per share of -0.23 yuan.

康霈生技の2025年第4四半期の収益状況はどうでしたか？

同社は2025年第4四半期に、税引後純利益-3.52億元、1株当たり純利益（EPS）-0.23元を記録しました。

Cite this article — HOW TO CITE

Washin AI News Desk“KANBO Biotech 2025 Q4 Financials”AI News by Washin Village（和心村）, Dec 1, 2025. https://aeo.idaeo.ai/ai/%E5%BA%B7%E9%9C%88%E7%94%9F%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-04-09-kangpei

AI CRAWLER ACTIVITY

as of Aug 20, 2026

AI crawler visits to this article (cumulative)31 bots

Site-wide cumulative

Applebot

bot_visits_summary

2425k

last Aug 20, 2026

GPTBot

bot_visits_summary

1904k

last Aug 20, 2026

ClaudeBot

bot_visits_summary

1261k

last Aug 20, 2026

Amazonbot

bot_visits_summary

673k

last Aug 20, 2026

Bingbot

bot_visits_summary

589k

last Aug 20, 2026

Meta AI

bot_visits_summary

350k

last Aug 20, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 康霈生技股份有限公司 Back to newsroom (14)

Copied